Prot #BTCRC GU19-404: A Single Arm, Phase I/II Trial of Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men with Localized, High Risk Prostate Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date6/24/216/24/24

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC GU19-404)
  • Genentech, Inc. (Prot #BTCRC GU19-404)